We bring intelligence, experience, connections and smart financial investment to the table.
We invest in cutting-edge companies across Europe that are changing the world.
We are driven by the belief that innovation offers compelling answers to the most pressing problems facing the world – achieving sustainable prosperity.
Connect with ETF Partners.

We'd love to hear from you. Drop us an email, give us a call or follow us on LinkedIn, Medium or Twitter.
ETF Digest

Eagle Genomics Announces USD 20M First Close; Scale-up Funding to Accelerate the Application of Microbiome Science for Global ‘One Health’ Innovation


2 November 2022


Congratulations to our portfolio company Eagle Genomics as they announce the $20 million first close of their scale-up funding round! 🚀🌎

Eagle Genomics continues to mature and expand as the leading TechBio company pioneering the application of network science to biological discovery and innovation, across the Food and Nutrition, AgBio, Beauty and Personal Care, and Biopharma industries. The company’s proprietary e[datascientist] platform enables enterprise customers to trace digital journeys in data, driving transformative innovations, exploiting leading-edge scientific discovery in silico and supporting differentiated product claims.

Discussing the announcement, our Managing Partner, Rob Genieser, commented:

We are delighted to see Eagle Genomics continue to mature and scale. The timing could not be better, with the world’s focus on disease and accelerated in silico innovation. At a time when there is an urgent requirement for systems change to support and protect the Biosphere, Eagle Genomics is helping drive sustainability and impact-focused business outcomes. We wish the team all the best in expanding its reach and deepening its capabilities.

Congratulations to the entire team and here’s to your continued success!

Read more HERE.